Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.
about
Could human papillomaviruses be spread through blood?Safety of human papillomavirus vaccines: a reviewHPV clearance and the neglected role of stochasticityEpidemiology of HPV Genotypes among HIV Positive Women in Kenya: A Systematic Review and Meta-Analysis.Guidelines for the Prevention and Treatment of Opportunistic Infections among HIV-exposed and HIV-infected children: recommendations from CDC, the National Institutes of Health, the HIV Medicine Association of the Infectious Diseases Society of AmerEpidemiology of HPV in HIV-positive and HIV-negative fertile women in Cameroon, West Africa.Association between cervical dysplasia and human papillomavirus in HIV seropositive women from Johannesburg South Africa.The impact of highly active antiretroviral therapy on prevalence and incidence of cervical human papillomavirus infections in HIV-positive adolescents.Genital warts and infection with human immunodeficiency virus in high-risk women in Burkina Faso: a longitudinal study.Type-specific incidence, clearance and predictors of cervical human papillomavirus infections (HPV) among young women: a prospective study in Uganda.The role of sexual behavior and human papillomavirus persistence in predicting repeated infections with new human papillomavirus types.Cervical pap screening cytological abnormalities among HIV-infected adolescents in the LEGACY cohort.Analysis of the effect of DNA purification on detection of human papillomavirus in oral rinse samples by PCR.Transitional probability-based model for HPV clearance in HIV-1-positive adolescent females.Guidelines for the prevention and treatment of opportunistic infections in HIV-exposed and HIV-infected children: recommendations from the National Institutes of Health, Centers for Disease Control and Prevention, the HIV Medicine Association of theHigh prevalence of human papillomavirus infections in urine samples from human immunodeficiency virus-infected men.HPV genotype distribution in cervical intraepithelial neoplasia among HIV-infected women in Pune, India.Suppression of Langerhans cell activation is conserved amongst human papillomavirus α and β genotypes, but not a µ genotype.Safety and immunogenicity of a quadrivalent human papillomavirus (types 6, 11, 16, and 18) vaccine in HIV-infected children 7 to 12 years old.Immune therapy for human papillomaviruses-related cancers.Human papillomavirus disease and vaccines in adolescents.Practice improvement in cervical screening and management (PICSM): symposium on management of cervical abnormalities in adolescents and young women.Incident anal human papillomavirus and human papillomavirus-related sequelae in HIV-infected versus HIV-uninfected adolescents in the United States.Incidence of sexually transmitted infections in HIV-infected and HIV-uninfected adolescents in the USA.High-risk human papillomavirus in HIV-infected women undergoing cervical cancer screening in Lilongwe, Malawi: a pilot study.Progression and regression of premalignant cervical lesions in HIV-infected women from Soweto: a prospective cohort.Sociodemographic and clinical factors of women with HPV and their association with HIVA shift to a peripheral Th2-type cytokine pattern during the carcinogenesis of cervical cancer becomes manifest in CIN III lesionsCervical cancer screening and treatment of cervical intraepithelial neoplasia in female sex workers using "screen and treat" approach.Impact of coverage-dependent marginal costs on optimal HPV vaccination strategies.CD4+ cell count and HIV load as predictors of size of anal warts over time in HIV-infected women.Incidence, prevalence, and epidemiology of herpes simplex virus-2 in HIV-1-positive and HIV-1-negative adolescentsBiology of human papillomavirus infection and immune therapy for HPV-related head and neck cancers.Immune response in cervical dysplasia induced by human papillomavirus: the influence of human immunodeficiency virus-1 co-infection -- review.Effect of Low CD4 Cell Count on Cervical Squamous Intraepithelial Lesions among HIV-Positive Women in Enugu, Southeastern NigeriaPrevalence and risk factors for HPV in HIV-positive young women receiving their first HPV vaccination.Highly active antiretroviral therapy and cervical dysplasia in HIV-positive women in South Africa.Disparities in human papillomavirus vaccine completion among vaccine initiators.Cytokine release in HR-HPV(+) women without and with cervical dysplasia (CIN II and III) or carcinoma, compared with HR-HPV(-) controls.Warts and all: human papillomavirus in primary immunodeficiencies.
P2860
Q24538854-0E29E634-B62D-4572-B37C-02B49CB108E4Q28082119-4A3F24DA-DA60-485E-B615-EE77A2556F3DQ28652424-DBA1BA9D-3C28-4BFA-8DE0-E2DBA72840BFQ30244304-D567ACA7-BD3A-40FF-93D4-55E44655F803Q33650105-30BD2BFE-16AD-48CA-8119-73CB0C48E290Q33652353-81C5FEE0-8B72-4123-8707-DCCE8E85E999Q33716047-326B646A-C003-4DCA-A722-3D6892A5D991Q33718690-CEC38CD7-56A2-4BD5-8EB7-FDBD8C885D0DQ33798628-2BB3477F-23D0-40BD-85BB-4E9E18C45862Q33863369-90AD050C-2614-4B40-B94F-6179F01E37D2Q34059901-E59F1B47-3D9D-4941-BDB3-9D3389FDA357Q34124803-34D0A464-FF78-4967-AC1B-67B800A92F42Q34143873-49382D73-1E4F-4ED0-889A-592520B93F63Q34146342-37F35B7F-0D67-48CE-ABF5-C2D0222BE213Q34212799-87CB5EE9-3FAE-4995-9DC8-67B456FC8CB6Q34231736-8E0437AD-1DE6-49F4-9B38-95A2120AC034Q34313933-32A0C77F-1EA3-4579-930C-3DD8A8743FF6Q34408919-8C2D5F32-83C9-4FCD-A1FC-C233199105B8Q34549645-A998FAD4-1234-4E40-BC9E-E636AB22E55AQ34657561-83DC2A6A-F9C6-48FE-A57E-EAD09F4170ADQ34675079-9C4F2B1B-7045-4DEB-B449-A7C356B0259DQ34684543-13897362-16D4-4239-AF35-35119389E40DQ35037011-DD442716-0434-4037-83F7-702E88CF56D7Q35082627-576FE82E-500C-4C94-A647-42196739A29DQ35186321-CF8A9A74-637E-4EFC-9173-FA5823266879Q35195833-D53264E0-2462-4144-A4AE-A89A4D74E4B9Q35222818-CD015F00-339A-407D-B7B7-AA93099A6E03Q35588773-577BD817-6EDB-467F-BA5E-6A868C736DD3Q35592340-F46ABCE4-FBBE-4F69-86CC-893C3E42B079Q35612736-2C0EE634-4663-4774-A015-3B0060514207Q35694739-AED1C449-1845-4805-B741-79153A91F7B1Q35836846-DB7E8764-2DB9-46C4-ABAB-1D4ECDD68037Q36099498-957616CF-0C5C-4F2D-B6E0-8203A50A78DEQ36114379-5B6B1227-6150-4E06-AFFE-67B38118DE51Q36343636-A8D5FAC6-7864-409B-A4D3-9D5300105D6EQ36346755-2E35E79B-683C-4CC1-94AE-55D67600B457Q36404058-0A6C2DBB-02B3-4651-A67D-BCA693CA74FEQ36416348-5D8FF590-D96C-4333-80FA-42B81CF6B49EQ36417513-C2C96A3F-AD0B-45ED-B92D-E32E760BD265Q36455030-B96F7141-F203-4456-A679-6D40B7F3545A
P2860
Persistence of human papillomavirus infection in HIV-infected and -uninfected adolescent girls: risk factors and differences, by phylogenetic type.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Persistence of human papilloma ...... erences, by phylogenetic type.
@en
Persistence of human papilloma ...... erences, by phylogenetic type.
@nl
type
label
Persistence of human papilloma ...... erences, by phylogenetic type.
@en
Persistence of human papilloma ...... erences, by phylogenetic type.
@nl
prefLabel
Persistence of human papilloma ...... erences, by phylogenetic type.
@en
Persistence of human papilloma ...... erences, by phylogenetic type.
@nl
P2093
P356
P1476
Persistence of human papilloma ...... erences, by phylogenetic type.
@en
P2093
Anna-Barbara Moscicki
Jiahong Xu
Jonas H Ellenberg
Sepideh Farhat
P356
10.1086/421467
P407
P577
2004-06-08T00:00:00Z